A research group from Nagoya University in Japan has developed an artificial intelligence for analyzing cell images that uses machine learning to predict the therapeutic effect of drugs. Called in silico FOCUS, this new technology may aid in the discovery of therapeutic agents for neurodegenerative disorders such as Kennedy disease.

A new study found that chronic kidney disease (CKD) patients who received IV contrast-enhanced imaging faced no more risk of developing contrast-induced nephropathy than those who did not receive contrast material. Matt O'Connor | Diagnostic Imaging | Health Imaging